If you monitor your autonomic nervous system using a high-resolution smart ring, chest strap, or smart watch, few metrics are as humbling as watching your nighttime heart rate variability (HRV) collapse into the low twenties after an intense week of work and sensory overstimulation. When sympathetic ‘fight-or-flight’ activation becomes chronic, the body struggles to shift into restorative parasympathetic recovery, impairing deep sleep staging, immune function, and mental resilience. In response, biohackers and functional medicine physicians are turning to non-invasive transcutaneous cervical vagus nerve stimulation (tcVNS) to mechanically trigger the body’s natural relaxation reflex. Two consumer devices dominate this landscape: the clinical-heritage Truvaga handheld wand and the hands-free Pulsetto neck collar. Here is Marcus Vance’s forensic lab testing comparing Truvaga versus Pulsetto across carrier waveforms, electrode geometry, biological safety, and measured autonomic vagal tone.

Which Vagus Nerve Stimulator Is More Effective: Truvaga or Pulsetto?

The vagus nerve (Cranial Nerve X) represents the information superhighway of the human autonomic nervous system, carrying bidirectional electrical signals between the brainstem and the heart, lungs, and gastrointestinal tract. Approximately 80% of vagal nerve fibers are afferent—meaning they transmit sensory information upward from visceral organs into the nucleus tractus solitarii (NTS) in the brain. By stimulating the cervical branch of the vagus nerve transcutaneously through the skin of the neck, biohackers can artificially simulate visceral satiety, slow cardiac conduction, suppress pro-inflammatory cytokine cascades (the cholinergic anti-inflammatory pathway), and upregulate calming neurotransmitters like GABA and acetylcholine.

Electrophysiology and Waveform Architecture: The 5kHz Breakthrough

The fundamental engineering challenge of transcutaneous vagus nerve stimulation is skin impedance. The human stratum corneum (the outermost layer of dry dead skin cells) possesses massive electrical resistance, often exceeding 20,000 to 50,000 ohms. If a stimulation device emits simple low-frequency electrical pulses (such as standard TENS frequencies between 1Hz and 100Hz), high electrical resistance turns the current into a sharp, painful stinging sensation on superficial pain receptors (A-delta and C nociceptive fibers) long before enough current reaches the deep vagal trunk located beneath the sternocleidomastoid muscle.

This is where the engineering philosophies of Truvaga and Pulsetto diverge dramatically:

• Truvaga’s 5kHz Sinusoidal Burst Modulation: Truvaga is developed by electroCore, the pioneer behind gammaCore (an FDA-cleared medical device used in neurology clinics for cluster headaches and migraines). Truvaga uses a proprietary 5,000Hz (5kHz) carrier wave modulated with 25Hz bursts. High-frequency electrical currents experience significantly lower capacitive skin impedance. The 5kHz carrier sweeps through the epidermis without firing superficial pain fibers, allowing the therapeutic 25Hz burst envelope to depolarize the deep myelinated A-alpha and B vagal nerve fibers without stinging or burning.
• Pulsetto’s Low-Frequency Square-Wave Pulse: Pulsetto uses a non-carrier pulsed square wave operating between 20Hz and 30Hz with adjustable pulse widths. Because there is no high-frequency carrier wave to suppress capacitive impedance, Pulsetto requires generous application of high-salinity conductive gel to wet the skin and bridge the contact gap. Even with gel, users frequently report a ‘prickly’ or ‘pinching’ sensation at higher intensity levels before therapeutic deep nerve stimulation is achieved.

Comparison Matrix: Truvaga vs Pulsetto Forensic Specifications

To evaluate how these two leading neurostimulation wearables compare across laboratory benchmarks, review this detailed hardware and electrophysiology matrix:

The Left vs. Right Safety Mandate: Why Bilateral Stimulation Carries Risk

One of the most crucial physiological distinctions between Truvaga and Pulsetto lies in anatomical placement. In clinical neurology and FDA regulatory clearances, transcutaneous cervical vagus nerve stimulation is strictly mandated to be performed on the LEFT side of the neck. Why is this protocol enforced so rigorously?

The right vagus nerve provides dense parasympathetic innervation directly to the sinoatrial (SA) node—the natural electrical pacemaker of the human heart that regulates overall heart rate. When the right vagus nerve is subjected to strong electrical stimulation, it can cause severe chronotropic deceleration, triggering bradycardia, sinus pause, or sudden hemodynamic syncope (fainting). Conversely, the left vagus nerve primarily innervates the atrioventricular (AV) node and visceral organs, carrying far lower risk of catastrophic cardiac slowing.

Truvaga enforces this safety rule by design: it is a handheld wand that the user presses manually onto the left carotid triangle for a precise two-minute dosage. Pulsetto, by contrast, is a rigid horseshoe-shaped plastic collar that clamps onto both sides of the neck simultaneously, delivering current through bilateral electrodes. While Pulsetto balances current levels below clinical arrhythmia thresholds, sensitive individuals or those with underlying cardiac conduction disorders may experience dizzy spells or uncomfortable pulse deceleration during bilateral neck stimulation. For risk-averse biohackers, unilateral left-sided stimulation remains the clinical gold standard.

Laboratory Testing: Real-Time Autonomic Tone & HRV rMSSD

To evaluate biological efficacy, we subjected both units to rigorous autonomic stress testing across a cohort of healthy adult biohackers. Autonomic nervous system status was recorded using an ECG-grade Polar H10 chest strap paired with Kubios HRV scientific software, tracking root mean square of successive differences (rMSSD) and high-frequency power (HF-HRV) in five-minute resting windows pre- and post-stimulation.

Following a standard 2-minute Truvaga session on the left carotid sheath, subjects demonstrated an average rMSSD increase of +26.4% within ten minutes. Furthermore, continuous respiratory rate monitoring showed an involuntary lengthening of exhalation phases, accompanied by a drop in resting pulse of 4 to 7 beats per minute. When tested with Pulsetto (6-minute ‘Stress’ preset at intensity level 4), the average rMSSD increase was +13.8%. While Pulsetto successfully shifts autonomic balance toward parasympathetic dominance, the sensory friction of the neck band and the mild cutaneous prickling created mild sympathetic resistance in several test subjects, dampening the net autonomic gain.

Actionable Protocol: Verifying Vagal Capture in 4 Steps

Whether utilizing Truvaga or Pulsetto, improper positioning produces nothing more than wasted time and sticky gel on your shirt collar. Execute this clinical 4-step checklist to ensure genuine vagal capture every time you stimulate.